CDC20 and glioblastoma: Nonetheless, we should perform further investigations to understand the biological significance of targeting PRMT6 and CDC20 in combination with PRMT6 and CDC20 inhibitors to synergistically attenuate GBM cell proliferation in vitro and in vivo.